News Briefs

SuppreMol Secures Series B

15 July 2008

SuppreMol GmbH, a German biopharmaceutical company developing novel therapeutics for the treatment of autoimmune diseases closed a

Get limited access to our industry news, analysis and data, plus regular email updates

Email address

First name

first name

Last name

last name

Organisation

Country Phone number Job title

Job Title

To register, please review and accept our terms and conditions and privacy notice. I accept: sourceRegistration

Register now